Bicara Therapeutics Inc. (BCAX) vs Replimune Group, Inc. (REPL)
Bicara Therapeutics Inc. and Replimune Group, Inc. are both Biotechnology companies. Bicara Therapeutics Inc. is the larger, with a market value of $1.3B against $1.2B — 1.1× the size. Across the 10 metrics below, Bicara Therapeutics Inc. leads on 9 and Replimune Group, Inc. on 1.
Valuation
Profitability
| Metric | BCAX | REPL | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (41.01%) | (134.29%) | (57.72%) |
| Return on assets | (38.38%) | (82.28%) | (49.22%) |
| Return on invested capital | 0.00% | (1,154.69%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack